Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How should I handle a request for additional documents for my application? Could this negatively affect my eventual approval?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q205 · Category E: Application Process and Approval Procedures (Q201-Q250)
Receiving a Request for Further Information from the Drug Office, Department of Health is a common occurrence during the application process and is no cause for undue concern. It usually means the reviewing officer has found something unclear, incomplete or inconsistent in your application materials. The appropriate response is to read the notice carefully and fully understand what the officer is asking you to provide or clarify. Then immediately prepare the requested documents or information, ensuring that your submission addresses every question precisely. Finally, submit it in writing, together with all supporting documents, by the specified deadline. A properly handled response will not usually have a direct adverse effect on the final decision, as the reviewing officer treats it as a process for clarifying the facts. It will, however, extend the overall approval timeline.

📘 Regulatory basis

A request for further information is itself part of the regulatory authority’s due diligence and is intended to ensure that all application information complies with the Pharmacy and Poisons Regulations. Applicants are obliged to cooperate with the regulatory authority and provide all information necessary for its review.

📗 Drew Tang's recommendations

When faced with a request for further information, the key is to respond “quickly” and “precisely”. We can help you interpret the official letter promptly and explain what it requires. For example, if evidence of a Responsible Person’s experience is requested, we can recommend more persuasive documents, such as a reference from a former employer or a description of relevant project experience, rather than a simple employment certificate.

📕 Risk notice

Mishandling a request for further information is a major risk. Examples include delaying submission, submitting materials that still do not meet the requirements, or responding in a confrontational manner to the officers. Repeated requests for further information may give reviewing officers the impression that you are ill-prepared or unprofessional. While this will not directly result in rejection, it may make subsequent reviews more stringent and increase uncertainty.

Back to Category E: Application Process and Approval Procedures (Q201-Q250) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗